Autoimmune gastritis.
Journal
Nature reviews. Disease primers
ISSN: 2056-676X
Titre abrégé: Nat Rev Dis Primers
Pays: England
ID NLM: 101672103
Informations de publication
Date de publication:
09 07 2020
09 07 2020
Historique:
accepted:
26
05
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
10
4
2021
Statut:
epublish
Résumé
Autoimmune gastritis (AIG) is an increasingly prevalent, organ-specific, immune-mediated disorder characterized by the destruction of gastric parietal cells, leading to the loss of intrinsic factor and reduced acid output. These alterations result in malabsorption of iron, vitamin B
Identifiants
pubmed: 32647173
doi: 10.1038/s41572-020-0187-8
pii: 10.1038/s41572-020-0187-8
doi:
Substances chimiques
Receptors, Thyrotropin
0
TSHR protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
56Références
Solcia, E. et al. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J. Biol. Med. 65, 793–804 (1992). This paper describes the pathological characterization of autoimmune gastritis.
pubmed: 1341079
pmcid: 2589778
Neumann, W. L., Coss, E., Rugge, M. & Genta, R. M. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat. Rev. Gastroenterol. Hepatol. 10, 529–541 (2013).
pubmed: 23774773
Di Sabatino, A., Lenti, M. V., Giuffrida, P., Vanoli, A. & Corazza, G. R. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun. Rev. 14, 1161–1169 (2015).
pubmed: 26275585
Hunt, R. H. et al. The stomach in health and disease. Gut 64, 1650–1668 (2015).
pubmed: 26342014
pmcid: 4835810
Rugge, M. et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment. Pharmacol. Ther. 16, 1249–1259 (2002).
pubmed: 12144574
Graham, D. Y. & Rugge, M. Clinical practice: diagnosis and evaluation of dyspepsia. J. Clin. Gastroenterol. 44, 167–172 (2010).
pubmed: 20009950
pmcid: 2828509
Sugano, K. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64, 1353–1367 (2015). This is the latest consensus on classification of gastritis.
pubmed: 26187502
pmcid: 4552923
Fox, J. G. & Wang, T. C. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117, 60–69 (2007).
pubmed: 17200707
Achord, J. L. & Muthusamy, V. R. in Clinical Gastrointestinal Endoscopy 3rd edn (eds Chandrasekhara, V., Elmunzer, B. J., Khashab, M. & Muthusamy, V. R.) 2–11 (Elsevier, 2019).
Taylor, K. B. Inhibition of intrinsic factor by pernicious anaemia sera. Lancet 2, 106–108 (1959).
pubmed: 13837172
Taylor, K. B., Roitt, I. M., Doniach, D., Couchman, K. G. & Shapland, C. Autoimmune phenomena in pernicious anaemia: gastric antibodies. BMJ 2, 1347–1352 (1962).
pubmed: 13993616
Strickland, R. G. & Mackay, I. R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am. J. Dig. Dis. 18, 426–440 (1973).
pubmed: 4573514
De Block, C. E. M. et al. Soluble transferrin receptor level: a new marker of iron deficiency anaemia, a common manifestation of gastric autoimmunity in type 1 diabetes. Diabetes Care 23, 1384–1388 (2000).
pubmed: 10977038
Hershko, C. et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 107, 1673–1679 (2006).
pubmed: 16239424
De Block, C. E., De Leeuw, I. H. & Van Gaal, L. F. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J. Clin. Endocrinol. Metab. 93, 363–371 (2008).
pubmed: 18029461
Marignani, M. et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am. J. Gastroenterol. 94, 766–772 (1999).
pubmed: 10086664
Toh, B. H., van Driel, I. R. & Gleeson, P. A. Pernicious anemia. N. Engl. J. Med. 337, 1441–1448 (1997).
pubmed: 9358143
Toh, B. H. & Alderuccio, F. Pernicious anemia. Autoimmunity 37, 357–361 (2004).
pubmed: 15518059
Lahner, E. & Annibale, B. Pernicious anemia: new insights from a gastroenterological point of view. World J. Gastroenterol. 15, 5121–5128 (2009).
pubmed: 19891010
pmcid: 2773890
Lenti, M. V. et al. Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment. Pharmacol. Ther. 50, 167–175 (2019). This is the first study exploring diagnostic delay in autoimmune gastritis.
pubmed: 31115910
Lenti, M. V. et al. Infertility and recurrent miscarriage in a patient with autoimmune atrophic gastritis. Intern. Emerg. Med. 13, 815–816 (2018).
pubmed: 29524079
Lahner, E. et al. Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists (AIGO), the Italian Society of Digestive Endoscopy (SIED), the Italian Society of Gastroenterology (SIGE), and the Italian Society of Internal Medicine (SIMI). Dig. Liver Dis. 51, 1621–1632 (2019). This is a position paper regarding proper diagnosis and management of atrophic gastritis.
pubmed: 31635944
Miceli, E. et al. Natural history of autoimmune atrophic gastritis: a prospective, single-institution, long-term experience. Aliment. Pharmacol. Ther. 50, 1172–1180 (2019). This paper describes the long-term natural history of autoimmune gastritis, with a description of potential autoimmune gastritis.
pubmed: 31621927
Lenti, M. V., Miceli, E., Corazza, G. R. & Di Sabatino, A. Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis–a salutary lesson. Authors’ reply. Aliment. Pharmacol. Ther. 50, 459–460 (2019).
pubmed: 31359467
Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20, 1161–1181 (1996). This paper discusses the most widely used classification of gastritis.
pubmed: 8827022
Misiewicz, J. J. The Sydney system: a new classification of gastritis. Introduction. J. Gastroenterol. Hepatol. 6, 207–208 (1991).
pubmed: 1912430
Green, R. et al. Vitamin B12 deficiency. Nat. Rev. Dis. Prim. 3, 17040 (2017).
pubmed: 28660890
Lahner, E. et al. Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter 19, 417–424 (2014).
pubmed: 25231208
Toh, B. H. Diagnosis and classification of autoimmune gastritis. Autoimmun. Rev. 13, 459–462 (2014).
pubmed: 24424193
Rusak, E., Chobot, A., Krzywicka, A. & Wenzlau, J. Anti-parietal cell antibodies – diagnostic significance. Adv. Med. Sci. 61, 175–179 (2016).
pubmed: 26918709
Massironi, S. et al. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun. Rev. 18, 215–222 (2019).
pubmed: 30639639
Zhang, H. et al. Autoimmune metaplastic atrophic gastritis in Chinese: a study of 320 patients at a large tertiary medical center. Scand. J. Gastroenterol. 52, 150–156 (2017).
pubmed: 27652682
Notsu, T. et al. Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan. Intern. Med. 58, 1817–1823 (2019).
pubmed: 30918182
pmcid: 6663548
Miceli, E. et al. Common features of patients with autoimmune atrophic gastritis. Clin. Gastroenterol. Hepatol. 10, 812–814 (2012).
pubmed: 22387252
Wolf, E. M. et al. Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study. Dig. Liver Dis. 46, 412–418 (2014).
pubmed: 24484998
Lahner, E. et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am. J. Gastroenterol. 104, 2071–2079 (2009).
pubmed: 19491828
Carmel, R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch. Intern. Med. 156, 1097–1100 (1996).
pubmed: 8638997
Carmel, R. & Johnson, C. S. Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N. Engl. J. Med. 298, 647–650 (1978).
pubmed: 628388
Carmel, R., Johnson, C. S. & Weiner, J. M. Pernicious anemia in Latin Americans is not a disease of the elderly. Arch. Intern. Med. 147, 1995–1996 (1987).
pubmed: 3675102
Kocak, R. & Paydas, S. Pernicious anemia in Turkey. Int. J. Hematol. 55, 117–119 (1992).
pubmed: 1511161
Carabotti, M. et al. Upper gastrointestinal symptoms in autoimmune gastritis: a crosssectional study. Medicine 96, e5784 (2017).
pubmed: 28072728
pmcid: 5228688
Lenti, M. V. et al. Cell blood count alterations and patterns of anaemia in autoimmune atrophic gastritis at diagnosis: a multicentre study. J. Clin. Med. 8, 1992 (2019).
pmcid: 6912578
Dickey, W. et al. Gastric as well as duodenal biopsies may be useful in the investigation of iron deficiency anaemia. Scand. J. Gastroenterol. 32, 469–472 (1997).
pubmed: 9175209
Annibale, B. et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am. J. Med. 111, 439–445 (2001).
pubmed: 11690568
Kulnigg-Dabsch, S., Resch, M., Gasche, A. & Gasche, C. Autoimmune gastritis is common in patients with iron deficiency – non-invasive evaluation of iron deficiency aside guideline recommendations [abstract Sa2034]. Gastroenterology 148 (4 Suppl. 1), S-389 (2015).
Hershko, C. et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 90, 585–595 (2005).
pubmed: 15921373
Kokkola, A. et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia: a prospective follow-up study. Scand. J. Gastroenterol. 33, 88–92 (1998).
pubmed: 9489914
De Block, C. E. et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 26, 82–88 (2003).
pubmed: 12502662
Grozinsky-Glasberg, S. et al. Gastric carcinoids. Endocrinol. Metab. Clin. N. Am. 47, 645–660 (2018).
Lahner, E. et al. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scand. J. Gastroenterol. 50, 856–865 (2015).
pubmed: 25645880
Hsing, A. et al. Pernicious anemia and subsequent cancer: a population-based cohort study. Cancer 71, 745–750 (1993).
pubmed: 8431855
Vannella, L. et al. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment. Pharmacol. Ther. 37, 375–382 (2013).
pubmed: 23216458
Correa, P. & Piazuelo, M. B. Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol. Hepatol. Rev. 7, 59–64 (2011).
pubmed: 21857882
pmcid: 3158605
Mahmud, N. et al. The incidence of neoplasia in patients with autoimmune metaplastic atrophic gastritis: a renewed call for surveillance. Ann. Gastroenterol. 32, 67–72 (2019).
pubmed: 30598594
Husebye, E. S., Anderson, M. S. & Kämpe, O. Autoimmune polyendocrine syndromes. N. Engl. J. Med. 378, 2543–2544 (2018).
pubmed: 29949487
Hughes, J. W. et al. High-risk gastric pathology and prevalent autoimmune diseases in patients with pernicious anemia. Endocr. Pract. 23, 1297–1303 (2017).
pubmed: 29190137
Lahner, E. et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am. J. Med. 121, 136–141 (2008).
pubmed: 18261502
De Block, C. E., De Leeuw, I. H. & Van Gaal, L. F. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian diabetes registry. J. Clin. Endocrinol. Metab. 84, 4062–4067 (1999).
pubmed: 10566650
Kozhakhmetova, A. et al. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. Clin. Exp. Immunol. 192, 251–258 (2018).
pubmed: 29431870
pmcid: 5980499
Zelissen, M. J., Bast, E. J. E. G. & Croughs, R. J. M. Associated autoimmunity in Addison’s disease. J. Autoimmun. 8, 121–130 (1995).
pubmed: 7734032
Zauli, D. et al. Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion 34, 169–172 (1986).
pubmed: 3758513
Dahir, A. M. & Thomsen, S. F. Comorbidities in vitiligo: comprehensive review. Int. J. Dermatol. 57, 1157–1164 (2018).
pubmed: 29808541
Massironi, S. et al. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur. J. Endocrinol. 168, 755–761 (2013).
pubmed: 23447517
Chang, K. H., Lyu, R. K., Ro, L. S., Wu, Y. R. & Chen, C. M. Coexistence of pernicious anemia and myasthenia gravis–a rare combination of autoimmune diseases in Taiwan. J. Formos. Med. Assoc. 105, 946–949 (2006).
pubmed: 17098697
Nenna, R. et al. Endoscopic and histological gastric lesions in children with celiac disease: mucosal involvement is not only confined to the duodenum. J. Pediatr. Gastroenterol. Nutr. 55, 728–732 (2012).
pubmed: 22773062
Kolkhir, P. et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun. Rev. 16, 1196–1208 (2017).
pubmed: 29037900
Rodriguez-Castro, K. I. et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 89, 100–103 (2018).
pubmed: 30561426
Jevremovic, D., Torbenson, M., Murray, J. A., Burgart, L. J. & Abraham, S. C. Atrophic autoimmune pangastritis: a distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am. J. Surg. Pathol. 30, 1412–1419 (2006).
pubmed: 17063082
Vanderlocht, J., van der Cruys, M., Stals, F., Bakker-Jonges, L. & Damoiseaux, J. Multiplex autoantibody detection for autoimmune liver diseases and autoimmune gastritis. J. Immunol. Methods 448, 21–25 (2017).
pubmed: 28522403
Jacobson, D. L., Gange, S. J., Rose, N. R. & Graham, N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223–243 (1997).
pubmed: 9281381
Pogoriler, J., Kamin, D. & Goldsmith, J. D. Pediatric non-Helicobacter pylori atrophic gastritis: a case series. Am. J. Surg. Pathol. 39, 786–792 (2015).
pubmed: 25602795
Saglietti, C. et al. Autoimmune gastritis in the pediatric age: an underestimated condition report of two cases and review. Front. Pediatr. 6, 123 (2018).
pubmed: 29765934
pmcid: 5939145
Calcaterra, V. et al. Anti-gastric parietal cell antibodies for autoimmune gastritis screening in juvenile autoimmune thyroid disease. J. Endocrinol. Invest. 43, 81–86 (2020).
pubmed: 31264142
Soykan, I., Yakut, M., Keskin, O. & Bektaş, M. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion 86, 20–26 (2012).
pubmed: 22710370
Terao, S. et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig. Endosc. 32, 364–372 (2020).
pubmed: 31368581
Massironi, S. et al. Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study. BMC Gastroenterol. 18, 172 (2018).
pubmed: 30409113
pmcid: 6225568
Zilli, A., Cavalcoli, F., Ciafardini, C. & Massironi, S. Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: a single-institution observational study. Dig. Liver Dis. 51, 505–509 (2019).
pubmed: 30236765
Tenca, A. et al. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring. Neurogastroenterol. Motil. 28, 274–280 (2016).
pubmed: 26568317
Villanacci, V. et al. Autoimmune gastritis: relationships with anemia and Helicobacter pylori status. Scand. J. Gastroenterol. 52, 674–677 (2017).
pubmed: 28276835
Kalkan, Ç. & Soykan, I. Polyautoimmunity in autoimmune gastritis. Eur. J. Intern. Med. 31, 79–83 (2016).
pubmed: 27085391
Kalkan, Ç., Soykan, I., Soydal, Ç., Özkan, E. & Kalkan, E. Assessment of gastric emptying in patients with autoimmune gastritis. Dig. Dis. Sci. 61, 1597–1602 (2016).
pubmed: 26725066
Kalkan, Ç. & Soykan, I. Differences between older and young patients with autoimmune gastritis. Geriatr. Gerontol. Int. 17, 1090–1095 (2017).
pubmed: 27444719
Rugge, M. et al. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment. Pharmacol. Ther. 35, 1460–1466 (2012). This paper describes the method for assessing the risk of developing gastric cancer depending on extension and severity of gastric atrophy.
pubmed: 22519568
Shoenfeld, Y., Tincani, A. & Gershwin, M. E. Sex gender and autoimmunity. J. Autoimmun. 38, 71–73 (2012).
Negrini, R. et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111, 655–665 (1996).
pubmed: 8780570
Fong, T. L. et al. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 100, 328–332 (1991).
pubmed: 1985031
Presotto, F. et al. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter 8, 578–584 (2003).
pubmed: 14632671
Annibale, B. et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter 12, 23–30 (2007).
pubmed: 17241297
Negrini, R. et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 101, 437–445 (1991).
pubmed: 2065920
Lahner, E. et al. Luminescent immunoprecipitation system (LIPS) for detection of autoantibodies against ATP4A and ATP4B subunits of gastric proton pump H+,K+-ATPase in atrophic body gastritis patients. Clin. Transl Gastroenterol. 8, e215 (2017).
pubmed: 28102858
pmcid: 5288605
Baxter, A. G., Jordan, M. A., Silveira, P. A., Wilson, W. E. & Van Driel, I. R. Genetic control of susceptibility to autoimmune gastritis. Int. Rev. Immunol. 24, 55–62 (2005).
pubmed: 15763989
Delva, P. L., MacDonell, J. E. & MacIntosh, O. C. Megaloblastic anemia occurring simultaneously white female monozygotic twins. Can. Med. Assoc. J. 92, 1129–1131 (1965).
pubmed: 14285300
pmcid: 1928324
Ungar, B., Mathews, J. D., Tait, B. D. & Cowling, D. C. HLA patterns in pernicious anaemia. Br. Med. J. 1, 798–800 (1977).
pubmed: 856385
pmcid: 1606137
Ungar, B., Mathews, J. D., Tait, B. D. & Cowling, D. C. HLA-DR patterns in pernicious anaemia. Br. Med. J. 282, 768–770 (1981).
De Block, C. E. M. et al. the Belgian diabetes registry. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in type 1 diabetes. Diabet. Med. 17, 618–622 (2000).
pubmed: 11073185
Lahner, E. et al. HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population. Dig. Liver Dis. 42, 854–859 (2010).
pubmed: 20627832
Oksanen, A. M., Haimila, K. E., Rautelin, H. I. & Partanen, J. A. Immunogenetic characteristics of patients with autoimmune gastritis. World J. Gastroenterol. 16, 354–358 (2010).
pubmed: 20082482
pmcid: 2807957
Arango, M. T. et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol. Res. 65, 82–98 (2017).
pubmed: 27435705
Howlett, M. et al. IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut 61, 1398–1409 (2012).
pubmed: 22180059
Bockerstett, K. A. et al. Interleukin-17A promotes parietal cell atrophy by inducing apoptosis. Cell. Mol. Gastroenterol. Hepatol. 5, 678–690 (2018).
pubmed: 29930985
pmcid: 6009015
Hata, M. et al. GPR30-expressing gastric chief cells do not dedifferentiate but are eliminated via PDK-dependent cell competition during development of metaplasia. Gastroenterology 158, 1650–1666.e15 (2020).
pubmed: 32032583
Sáenz, J. B., Vargas, N. & Mills, J. C. Tropism for spasmolytic polypeptide-expressing metaplasia allows Helicobacter pylori to expand its intragastric niche. Gastroenterology 156, 160–174 (2019).
pubmed: 30287170
Yoshizawa, N. et al. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab. Invest. 87, 1265–1276 (2007).
pubmed: 18004396
Silberg, D. G. et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122, 689–696 (2002).
pubmed: 11875002
Mutoh, H. et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem. Biophys. Res. Commun. 294, 470–479 (2002).
pubmed: 12051735
Giroux, V. & Rustgi, A. K. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat. Rev. Cancer 17, 594–604 (2017).
pubmed: 28860646
pmcid: 5998678
Rugge, M., Capelle, L. G., Cappellesso, R., Nitti, D. & Kuipers, E. J. Precancerous lesions in the stomach: from biology to clinical patient management. Best. Pract. Res. Clin. Gastroenterol. 27, 205–223 (2013).
pubmed: 23809241
Rugge, M. et al. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum. Pathol. 42, 1539–1544 (2011).
pubmed: 21481917
Fassan, M. et al. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am. J. Clin. Pathol. 137, 727–732 (2012).
pubmed: 22523210
Coati, I. et al. Autoimmune gastritis: pathologist’s viewpoint. World J. Gastroenterol. 21, 12179–12189 (2015).
pubmed: 26576102
pmcid: 4641135
El-Zimaity, H., Choi, W. T., Lauwers, G. Y. & Riddell, R. The differential diagnosis of Helicobacter pylori negative gastritis. Virchows Arch. 473, 533–550 (2018).
pubmed: 30255340
Graham, D. Y., Rugge, M. & Genta, R. M. Diagnosis: gastric intestinal metaplasia – what to do next? Curr. Opin. Gastroenterol. 35, 535–543 (2019).
pubmed: 31415250
Rugge, M. et al. Letter: gastric cancer and pernicious anaemia–often Helicobacter pylori in disguise. Aliment. Pharmacol. Ther. 37, 764–765 (2013).
pubmed: 23458544
Zambon, C. F. et al. Helicobacter pylori virulence genes and host IL-1RN and IL-1β genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 18, 242–251 (2002).
pubmed: 12161099
Alderuccio, F., Sentry, J. W., Marshall, A. C., Biondo, M. & Toh, B. H. Animal models of human disease: experimental autoimmune gastritis–a model for autoimmune gastritis and pernicious anemia. Clin. Immunol. 102, 48–58 (2002).
pubmed: 11781067
Field, J., Biondo, M. A., Murphy, K., Alderuccio, F. & Toh, B. H. Experimental autoimmune gastritis: mouse models of human organ-specific autoimmune disease. Int. Rev. Immunol. 24, 93–110 (2005).
pubmed: 15763991
Kobayashi, Y., Murakami, H., Akbar, S. M., Matsui, H. & Onji, M. A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid. Clin. Exp. Immunol. 136, 423–431 (2004).
pubmed: 15147343
pmcid: 1809059
Scarff, K. J., Pettitt, J. M., Van Driel, I. R., Gleeson, P. A. & Toh, B. H. Immunization with gastric H+/K(+)-ATPase induces a reversible autoimmune gastritis. Immunology 92, 91–98 (1997).
pubmed: 9370929
pmcid: 1363986
Silveira, P. A., Baxter, A. G., Cain, W. E. & van Driel, I. R. A major linkage region on distal chromosome 4 confers susceptibility to mouse autoimmune gastritis. J. Immunol. 162, 5106–5111 (1999).
pubmed: 10227980
Tanaka, N. & Glass, V. B. Effect of prolonged administration of parietal cell antibodies from patients with atrophic gastritis and pernicious anemia on the parietal cell mass and hydrochloric acid output in rats. Gastroenterology 58, 482–494 (1970).
pubmed: 4908769
Nishiura, H. et al. Increased susceptibility to autoimmune gastritis in thymic stromal lymphopoietin receptor-deficient mice. J. Immunol. 188, 190–197 (2012).
pubmed: 22124119
Rochman, Y. & Leonard, W. J. The role of thymic stromal lymphopoietin in CD8+ T cell homeostasis. J. Immunol. 181, 7699–7705 (2008).
pubmed: 19017958
pmcid: 2735224
Martinelli, T. M., van Driel, I. R., Alderuccio, F., Gleeson, P. A. & Toh, B. H. Analysis of mononuclear cell infiltrate and cytokine production in murine autoimmune gastritis. Gastroenterology 110, 1791–1802 (1996).
pubmed: 8964405
Nishiura, H. et al. Interleukin-21 and tumor necrosis factor-α are critical for the development of autoimmune gastritis in mice. J. Gastroenterol. Hepatol. 28, 982–991 (2013).
pubmed: 23425147
Tu, E. et al. Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritis. Eur. J. Immunol. 42, 2574–2583 (2012).
pubmed: 22777705
Karlsson, F. A., Burman, P., Lööf, L. & Mårdh, S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J. Clin. Invest. 81, 475–479 (1988). This paper reports the discovery of the target autoantigen of anti-parietal cell antibodies.
pubmed: 2828428
pmcid: 329594
Song, Y. H. et al. Localization of a pernicious anaemia autoantibody epitope on the α-subunit of human H,K-adenosine triphosphatase. Scand. J. Gastroenterol. 29, 122–127 (1994).
pubmed: 7513438
Callaghan, J. M. et al. α and β subunits of the gastric H+/K(+)-ATPase are concordantly targeted by parietal cell autoantibodies associated with autoimmune gastritis. Autoimmunity 16, 289–295 (1993).
pubmed: 7517707
De Aizpurua, H. J., Cosgrove, L. J., Ungar, B. & Toh, B. H. Autoantibodies cytotoxic to gastric parietal cells in serum of patients with pernicious anemia. N. Engl. J. Med. 309, 625–629 (1983).
pubmed: 6888429
Lenti, M. V., Miceli, E., Padula, D., Di Sabatino, A. & Corazza, G. R. The challenging diagnosis of autoimmune atrophic gastritis. Scand. J. Gastroenterol. 52, 471–472 (2017).
pubmed: 28040990
Pikkarainen, S. et al. A high prevalence of gastrointestinal manifestations in common variable immunodeficiency. Am. J. Gastroenterol. 114, 648–655 (2019).
pubmed: 30747770
pmcid: 6455088
Bedeir, A. S., Lash, R. H., Lash, J. G. & Ray, M. B. Significant increase in IgG4+ plasma cells in gastric biopsy specimens from patients with pernicious anaemia. J. Clin. Pathol. 63, 999–1001 (2010).
pubmed: 20924031
D’Elios, M. M. et al. H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 120, 377–386 (2001).
pubmed: 11159878
Troilo, A. et al. Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia. Oncotarget 10, 2921–2929 (2019).
pubmed: 31080562
pmcid: 6499598
Giuffrida, P. et al. Defective spleen function in autoimmune gastrointestinal disorders. Intern. Emerg. Med. 15, 225–229 (2020).
pubmed: 31214883
Di Sabatino, A. et al. Association between defective spleen function and primary eosinophilic gastrointestinal disorders. J. Allergy Clin. Immunol. Pract. 6, 1056–1058 (2018).
pubmed: 29128338
Riva, M. A., Ferraina, F., Paleari, A., Lenti, M. V. & Di Sabatino, A. From sadness to stiffness: the spleen’s progress. Intern. Emerg. Med. 14, 739–743 (2019).
pubmed: 31152307
Faller, G. et al. Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Pathol. Res. Pract. 195, 243–246 (1999).
pubmed: 10337662
Amedei, A. et al. Molecular mimicry between Helicobacter pylori antigens and H+,K+-adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 198, 1147–1156 (2003).
pubmed: 14568977
pmcid: 2194239
Hooi, J. K. Y. et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153, 420–429 (2017).
pubmed: 28456631
Zhang, Y., Weck, M. N., Schöttker, B., Rothenbacher, D. & Brenner, H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol. Biomarkers Prev. 22, 821–826 (2013).
pubmed: 23456556
De, Re,V. et al. Polymorphism in toll-like receptors and Helicobacter pylori motility in autoimmune atrophic gastritis and gastric cancer. Cancers 11, 648 (2019).
Parsons, B. N. et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 13, e1006653 (2017).
pubmed: 29095917
pmcid: 5667734
Kopic, S., Murek, M. & Geibel, J. P. Revisiting the parietal cell. Am. J. Physiol. Cell Physiol. 298, C1–C10 (2010).
pubmed: 19889964
Cook, J. D., Brown, G. M. & Valberg, L. S. The effect of Achylia gastrica on iron absorption. J. Clin. Invest. 43, 1185–1191 (1964).
pubmed: 14171795
pmcid: 289599
Schade, S. G., Cohen, R. J. & Conrad, M. E. The effect of hydrochloric acid on iron absorption. N. Eng. J. Med. 279, 621–624 (1968).
Bezwoda, W. et al. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J. Lab. Clin. Med. 92, 108–116 (1978).
pubmed: 26726
Cavalcoli, F., Zilli, A., Conte, D. & Massironi, S. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis. World J. Gastroenterol. 23, 563–572 (2017).
pubmed: 28216963
pmcid: 5292330
Kahn, S. B. & Brodsky, I. Metabolic interrelationship between vitamin B12 and ascorbic acid in pernicious anemia. Blood 31, 55–65 (1968).
pubmed: 5638564
Sipponen, P. & Härkönen, M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand. J. Gastroenterol. 45, 133–138 (2010).
pubmed: 19958055
Recker, R. R. Calcium absorption and achlorhydria. N. Engl. J. Med. 313, 70–73 (1985).
pubmed: 4000241
Eastell, R. et al. Pernicious anaemia as a risk factor for osteoporosis. Clin. Sci. 82, 681–685 (1992).
pubmed: 1320549
Antico, A., Tozzoli, R., Giavarina, D., Tonutti, E. & Bizzaro, N. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of vitamin D with the immune system. Clin. Rev. Allergy Immunol. 42, 355–364 (2012).
pubmed: 21286859
Lahner, E. et al. Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms. Eur. J. Gastroenterol. Hepatol. 30, 1291–1296 (2018).
pubmed: 30161028
Russell, R. M. et al. Folic acid malabsorption in atrophic gastritis. Possible compensation bacterial folate synthesis. Gastroenterology 91, 1476–1482 (1986).
pubmed: 3770372
Carabotti, M. et al. Gastroesophageal reflux symptoms and microscopic esophagitis in a cohort of consecutive patients affected by atrophic body gastritis: a pilot study. Scand. J. Gastroenterol. 13, 1–6 (2019).
Bergamaschi, G., Di Sabatino, A. & Corazza, G. R. Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders. Br. J. Haematol. 182, 319–329 (2018).
pubmed: 29732532
Hammond, N., Wang, Y., Dimachkie, M. M. & Barohn, R. J. Nutritional neuropathies. Neurol. Clin. 31, 477–489 (2013).
pubmed: 23642720
pmcid: 4199287
Lindenbaum, J. et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318, 1720–1728 (1988).
pubmed: 3374544
Santarelli, L. et al. Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment. Pharmacol. Ther. 19, 107–111 (2004).
pubmed: 14687172
Reznikoff-Etiévant, M. F., Zittoun, J., Vaylet, C., Pernet, P. & Milliez, J. Low vitamin B(12) level as a risk factor for very early recurrent abortion. Eur. J. Obstet. Gynecol. Reprod. Biol. 104, 156–159 (2002).
pubmed: 12206930
Gaskins, A. J. et al. Association between serum folate and vitamin B-12 and outcomes of assisted reproductive technologies. Am. J. Clin. Nutr. 102, 943–950 (2015).
pubmed: 26354529
pmcid: 4588741
Chuang, J. S. et al. Diagnostic ELISA for parietal cell autoantibody using tomato lectin-purified gastric H+/K(+)-ATPase (proton pump). Autoimmunity 12, 1–7 (1992).
pubmed: 1319758
Sugiu, K. et al. Evaluation of an ELISA for detection of anti-parietal cell antibody. Hepatogastroenterology 53, 11–14 (2006).
pubmed: 16506368
Toh, B. H., Kyaw, T., Taylor, R., Pollock, W. & Schlumberger, W. Parietal cell antibody identified by ELISA is superior to immunofluorescence, rises with age and is associated with intrinsic factor antibody. Autoimmunity 45, 527–532 (2012). This paper discusses the assessment of the accuracy of different methods of detection of anti-parietal cell antibodies.
pubmed: 22779747
Khan, S. et al. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J. Clin. Pathol. 62, 439–441 (2009).
pubmed: 19398595
Tozzoli, R. et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimm. Rev. 10, 80–83 (2010).
Cabrera de Leon, A. et al. Factors associated with parietal cell autoantibodies in the general population. Immunol. Lett. 147, 63–66 (2012).
pubmed: 22771341
Bagnasco, M. et al. Estimate of the prevalence of anti-gastric parietal cell autoantibodies in healthy individuals is method dependent. Am. J. Clin. Pathol. 150, 285–292 (2018).
pubmed: 30007281
Di Sabatino, A. et al. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Dig. Liver Dis. 49, 947–956 (2017).
pubmed: 28733178
Alonso, N. et al. Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study. J. Endocrinol. Invest. 34, 340–344 (2011).
pubmed: 20530988
Lahner, E. et al. Measurement of autoantibodies to gastric H+,K+-ATPase (ATP4A/B) using a luciferase immunoprecipitation system (LIPS). Methods Mol. Biol. 1901, 113–131 (2019).
pubmed: 30539573
Korstanje, A., den Hartog, G., Biemond, I. & Lamers, C. B. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand. J. Gastroenterol. 37, 22–26 (2002).
Zagari, R. M. et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment. Pharmacol. Ther. 46, 657–667 (2017).
pubmed: 28782119
Checchi, S. et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J. Clin. Endocrinol. Metab. 92, 4346–4351 (2007).
pubmed: 17711921
Miceli, E. et al. A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study. J. Clin. Gastroenterol. 49, e1–e5 (2015).
pubmed: 24583750
Ruiz, B. et al. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology 39, 235–242 (2001).
pubmed: 11532033
Rugge, M. et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut 65, 721–725 (2016).
pubmed: 26927528
pmcid: 4853570
Carmack, S. W., Lash, R. H., Gulizia, J. M. & Genta, R. M. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv. Anat. Pathol. 16, 290–306 (2009).
pubmed: 19700939
Rugge, M. et al. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology 22, 9–15 (1993).
pubmed: 8436350
Correa, P. Chronic gastritis: a clinic-pathological classification. Am. J. Gastroenterol. 83, 504–509 (1988).
pubmed: 3364410
Owen, D. A. in Diagnostic Surgical Pathology Ch. 29. (ed. Sternberg S. S.) 939–948 (Raven Press, 1989).
Yardley, J. H. Pathology of chronic gastritis and duodenitis. Monogr. Pathol. 31, 69–143 (1990).
Dixon, M. F. in Gastrointestinal Pathology (ed. Williams G. T.) 1–40 (Springer, 1990).
Lewin, K. L., Riddell, R. H., Weinstein, W. M. Gastrointestinal pathology and its clinical implications 508–537 (Igaku-Shoin, 1992).
Appelman, H. D. Gastritis: terminology, etiology, and clinicopathological correlations: another biased view. Hum. Pathol. 25, 1006–1019 (1994).
pubmed: 7927305
Annibale, B. et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur. J. Gastroenterol. Hepatol. 13, 1449–1456 (2001).
pubmed: 11742193
Capurso, G. & Lahner, E. The interaction between smoking, alcohol and the gut microbiome. Best. Pract. Res. Clin. Gastroenterol. 31, 579–588 (2017).
pubmed: 29195678
Lahner, E. et al. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 9, 436–442 (2004).
pubmed: 15361083
Doorakkers, E., Lagergren, J., Engstrand, L. & Brusselaers, N. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population. Gut 67, 2092–2096 (2018).
pubmed: 29382776
Banks, M. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 68, 1545–1575 (2019).
pubmed: 31278206
pmcid: 6709778
Rugge, M. et al. OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients. Am. J. Gastroenterol. 113, 1621–1628 (2018).
pubmed: 30333540
Capelle, L. G. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest. Endosc. 71, 1150–1158 (2010).
pubmed: 20381801
Hemminki, K. et al. Autoimmune disease and subsequent digestive tract cancer by histology. Ann. Oncol. 23, 927–933 (2012).
pubmed: 21810731
Ye, W. & Nyren, O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut 52, 938–941 (2003).
pubmed: 12801947
pmcid: 1773712
Mellemkjoer, L. et al. [Pernicious anemia and risk of cancer in Denmark]. Ugeskr. Laeger 159, 4850–4853 (1997).
pubmed: 9273757
Armbrecht, U. et al. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut 31, 1105–1109 (1990).
pubmed: 2083855
pmcid: 1378732
Brinton, L. A. et al. Cancer risk following pernicious anaemia. Br. J. Cancer 59, 810–813 (1989).
pubmed: 2736218
pmcid: 2247229
Svendsen, J. H. et al. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand. J. Gastroenterol. 21, 16–20 (1986).
pubmed: 3952447
Murphy, G. et al. Cancer risk after pernicious anemia in the US elderly population. Clin. Gastroenterol. Hepatol. 13, 2282–2289 (2015).
pubmed: 26079040
pmcid: 4655146
Landgren, A. M. et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 117, 1163–1171 (2011).
pubmed: 21381009
Lahner, E. et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest. Endosc. 53, 443–448 (2001).
pubmed: 11275884
Pimentel-Nunes, P. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 51, 365–388 (2019). This paper discusses the latest guidelines for endoscopic surveillance of gastric precancerous lesions.
pubmed: 30841008
Pimentel-Nunes, P. et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 48, 723–730 (2016).
pubmed: 27280384
Esposito, G. et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 51, 515–521 (2019).
pubmed: 30577062
Lahner, E. et al. Cost of detecting gastric neoplasia by surveillance endoscopy in atrophic gastritis in Italy: a low risk country. Dig. Liver Dis. 49, 291–296 (2017).
pubmed: 28034664
Strickland, R. G., Fisher, J. M., Lewin, K. & Taylor, K. B. The response to prednisolone in atrophic gastritis: a possible effect on non-intrinsic factor-mediated vitamin B12 absorption. Gut 14, 13–19 (1973).
pubmed: 4571069
pmcid: 1412575
Jorge, A. D. & Sanchez, D. The effect of azathioprine on gastric mucosal histology and acid secretion in chronic gastritis. Gut 14, 104–106 (1973).
pubmed: 4696531
pmcid: 1412565
Camaschella, C. Iron-deficiency anemia. N. Engl. J. Med. 372, 1832–1843 (2015).
pubmed: 25946282
Muñoz, M., Gómez-Ramírez, S. & Bhandari, S. The safety of available treatment options for iron-deficiency anemia. Exp. Op. Drug. Safe. 17, 149–159 (2018).
Hershko, C. & Camaschella, C. How I treat unexplained refractory iron deficiency anemia. Blood 123, 326–333 (2014).
pubmed: 24215034
Pisani, A. et al. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol. Dial. Transplant. 30, 645–652 (2015).
pubmed: 25395392
Birgegard, G. et al. A randomized noninferiority trial of intravenous iron isomaltoside versus oral iron sulfate in patients with nonmyeloid malignancies and anemia receiving chemotherapy: the PROFOUND trial. Pharmacotherapy 36, 402–414 (2016).
pubmed: 26927900
pmcid: 5071650
Okam, M. M., Koch, T. A. & Tran, M. H. Iron supplementation, response in iron-deficiency anemia: analysis of five trials. Am. J. Med. 130, 991.e1–991.e8 (2017).
Evstatiev, R. et al. FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141, 846–853 (2011).
pubmed: 21699794
European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron containing medicines. EMA/579491/2013. EMA http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500151308.pdf (2013).
Wang, H. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst. Rev. 3, CD004655 (2018).
pubmed: 29543316
Andres, E., Fothergill, H. & Mecili, M. Efficacy of oral cobalamin (vitamin B12) therapy. Exp. Op. Pharmacother. 11, 249–256 (2010).
Talley, N. J., Weaver, A. L. & Zinsmeister, A. R. Impact of functional dyspepsia on quality of life. Dig. Dis. Sci. 40, 584–589 (1995).
pubmed: 7895550
Yang, G. T., Zhao, H. Y., Kong, Y., Sun, N. N. & Dong, A. Q. Correlation between serum vitamin B12 level and peripheral neuropathy in atrophic gastritis. World J. Gastroenterol. 24, 1343–1352 (2018).
pubmed: 29599609
pmcid: 5871829
Kumar, N. Neurologic presentations of nutritional deficiencies. Neurol. Clin. 28, 107–170 (2010).
pubmed: 19932379
Morita, S., Miwa, H., Kihira, T. & Kondo, T. Cerebellar ataxia and leukoencephalopathy associated with cobalamin deficiency. J. Neurol. Sci. 216, 183–184 (2003).
pubmed: 14607321